1,301
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Tissue transglutaminase autoantibodies in children with newly diagnosed type 1 diabetes are related to human leukocyte antigen but not to islet autoantibodies: A Swedish nationwide prospective population-based cohort study

ORCID Icon, , , , , , , , , & show all
Pages 221-227 | Received 13 Nov 2017, Accepted 25 Jun 2018, Published online: 16 Nov 2018

References

  • Sud S, Marcon M, Assor E, et al. Celiac disease and pediatric type 1 diabetes: diagnostic and treatment dilemmas. Int J Pediatr Endocrinol. 2010;2010:161285
  • Redondo MJ, Steck AK, Pugliese A. Genetics of type 1 diabetes. Pediatr Diabetes. 2018;19:346–353.
  • Pham-Short A, Donaghue KC, Ambler G, et al. Screening for celiac disease in type 1 diabetes: a systematic review. Pediatrics. 2015;136:e170–e176.
  • Elfstrom P, Sundstrom J, Ludvigsson JF. Systematic review with meta-analysis: associations between coeliac disease and type 1 diabetes. Aliment Pharmacol Ther. 2014;40:1123–1132.
  • Bybrant MC, Ortqvist E, Lantz S, et al. High prevalence of celiac disease in Swedish children and adolescents with type 1 diabetes and the relation to the Swedish epidemic of celiac disease: a cohort study. Scand J Gastroenterol. 2014;49:52–58.
  • Larsson K, Carlsson A, Cederwall E, et al. Annual screening detects celiac disease in children with type 1 diabetes. Pediatr Diabetes. 2008;9:354–359.
  • Adlercreutz EH, Svensson J, Hansen D, et al. Prevalence of celiac disease autoimmunity in children with type 1 diabetes: regional variations across the Oresund strait between Denmark and southernmost Sweden. Pediatr Diabetes. 2015;16:504–509.
  • Dicke WK. Treatment of celiac disease. Ned Tijdschr Geneeskd. 1951;95:124–130.
  • Lohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007;26:1217–1225.
  • Ludvigsson JF, Rubio-Tapia A, van Dyke CT, et al. Increasing incidence of celiac disease in a North American population. Am J Gastroenterol. 2013;108:818–824.
  • Carlsson A, Agardh D, Borulf S, et al. Prevalence of celiac disease: before and after a national change in feeding recommendations. Scand J Gastroenterol. 2006;41:553–558.
  • Myleus A, Ivarsson A, Webb C, et al. Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr. 2009;49:170–176.
  • Bjorck S, Brundin C, Lorinc E, et al. Screening detects a high proportion of celiac disease in young HLA-genotyped children. J Pediatr Gastroenterol Nutr. 2010;50:49–53.
  • Liu E, Lee HS, Aronsson CA, et al. Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med. 2014;371:42–49.
  • Smigoc S, Mendez DA, Kunilo Jamnik S, et al. High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in cooccurrence of type 1 diabetes and celiac disease. Autoimmunity. 2016;49:240–247.
  • Gutierrez-Achury J, Romanos J, Bakker SF, et al. Contrasting the genetic background of type 1 diabetes and celiac disease autoimmunity. Diabetes Care. 2015;38:37–44.
  • Adlercreutz EH, Weile C, Larsen J, et al. A gluten-free diet lowers NKG2D and ligand expression in BALB/c and non-obese diabetic (NOD) mice. Clin Exp Immunol. 2014;177:391–403.
  • Aronsson CA, Lee HS, Liu E, et al. Age at gluten introduction and risk of celiac disease. Pediatrics. 2015;135:239–245.
  • Ivarsson A, Myleus A, Norstrom F, et al. Prevalence of childhood celiac disease and changes in infant feeding. Pediatrics. 2013;131:e687–e694.
  • Myleus A, Hernell O, Gothefors L, et al. Early infections are associated with increased risk for celiac disease: an incident case-referent study. BMC Pediatr. 2012;12:194.
  • Toftedal P, Nielsen C, Madsen JT, et al. Positive predictive value of serological diagnostic measures in celiac disease. Clin Chem Lab Med. 2010;48:685–691.
  • Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol. 2010;105:2520–2524.
  • Sandstrom O, Rosen A, Lagerqvist C, et al. Transglutaminase IgA antibodies in a celiac disease mass screening and the role of HLA-DQ genotyping and endomysial antibodies in sequential testing. J Pediatr Gastroenterol Nutr. 2013;57:472–476.
  • Sandstrom O, Rosen A, Ivarsson A. The Role of HLA-DQ Genotyping in Celiac Disease. J Pediatr Gastroenterol Nutr. 2016;62(3):e30–1.
  • Roep BO, Peakman M. Antigen targets of type 1 diabetes autoimmunity. Cold Spring Harb Perspect Med. 2012;2:a007781.
  • Berhan Y, Waernbaum I, Lind T, et al. Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes. 2011;60:577–581.
  • Andersson C, Vaziri-Sani F, Delli A, et al. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes. Pediatr Diabetes. 2013;14:97–105.
  • Andersson C, Larsson K, Vaziri-Sani F, et al. The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes. Autoimmunity. 2011;44:394–405.
  • Delli AJ, Lindblad B, Carlsson A, et al. Type 1 diabetes patients born to immigrants to Sweden increase their native diabetes risk and differ from Swedish patients in HLA types and islet autoantibodies. Pediatr Diabetes. 2010;11:513–520.
  • Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;30: S42–S47.
  • Hanberger L, Samuelsson U, Lindblad B, et al. A1C in children and adolescents with diabetes in relation to certain clinical parameters: the Swedish Childhood Diabetes Registry SWEDIABKIDS. Diabetes Care. 2008;31:927–929.
  • Kiviniemi M, Hermann R, Nurmi J, et al. A high-throughput population screening system for the estimation of genetic risk for type 1 diabetes: an application for the TEDDY (the Environmental Determinants of Diabetes in the Young) study. Diabetes Technol Ther. 2007;9:460–472.
  • Grubin CE, Daniels T, Toivola B, et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia. 1994;37:344–350.
  • Williams AJ, Bingley PJ, Bonifacio E, et al. A novel micro-assay for insulin autoantibodies. J Autoimmun. 1997;10:473–478.
  • Vaziri-Sani F, Delli AJ, Elding-Larsson H, et al. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes. J Immunol Methods. 2011;371:25–37.
  • Agardh D, Nilsson A, Tuomi T, et al. Prediction of silent celiac disease at diagnosis of childhood type 1 diabetes by tissue transglutaminase autoantibodies and HLA. Pediatr Diabetes. 2001;2:58–65.
  • Waisbourd-Zinman O, Hojsak I, Rosenbach Y, et al. Spontaneous normalization of anti-tissue transglutaminase antibody levels is common in children with type 1 diabetes mellitus. Dig Dis Sci. 2012;57:1314–1320.
  • Binder E, Loinger M, Mühlbacher A, et al. Genotyping of coeliac-specific human leucocyte antigen in children with type 1 diabetes: does this screening method make sense? Arch Dis Child. 2017;102:603–606.
  • Ludvigsson JF, Green PH. Clinical management of coeliac disease. J Intern Med. 2011;269:560–571.
  • Sollid LM, Markussen G, Ek J, et al. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med. 1989;169:345–350.
  • Bao F, Yu L, Babu S, et al. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun. 1999;13:143–148.
  • Viken MK, Flåm ST, Skrivarhaug T, et al. HLA class II alleles in Norwegian patients with coexisting type 1 diabetes and celiac disease. HLA. 2017;89:278–284.
  • Doolan A, Donaghue K, Fairchild J, et al. Use of HLA typing in diagnosing celiac disease in patients with type 1 diabetes. Diabetes Care. 2005;28:806–809.
  • Karell K, Louka AS, Moodie SJ, et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European genetics cluster on celiac disease. Hum Immunol. 2003;64:469–477.
  • Svensson M, Ramelius A, Nilsson AL, et al. Antibodies to influenza virus A/H1N1 hemagglutinin in Type 1 diabetes children diagnosed before, during and after the SWEDISH A(H1N1)pdm09 vaccination campaign 2009–2010. Scand J Immunol. 2014;79:137–148.
  • Wahlberg J, Fredriksson J, Vaarala O, et al. Vaccinations may induce diabetes-related autoantibodies in one-year-old children. Ann N Y Acad Sci. 2003;1005:404–408.
  • Adlercreutz EH, Wingren CJ, Vincente RP, et al. Perinatal risk factors increase the risk of being affected by both type 1 diabetes and coeliac disease. Acta Paediatr. 2015;104:178–184.
  • Andren Aronsson C, Lee HS, Koletzko S, et al. Effects of gluten intake on risk of celiac disease: a case-control study on a Swedish birth cohort. Clin Gastroenterol Hepatol. 2016;14:403–409 e3.
  • Hagopian W, Lee H-S, Liu E, et al. Co-occurrence of Type 1 Diabetes and celiac disease autoimmunity. Pediatrics Nov. 2017;140:e20171305.
  • Ivarsson A, Persson LA, Nystrom L, et al. The Swedish coeliac disease epidemic with a prevailing twofold higher risk in girls compared to boys may reflect gender specific risk factors. Eur J Epidemiol. 2003;18:677–684.
  • Megiorni F, Mora B, Bonamico M, et al. HLA-DQ and susceptibility to celiac disease: evidence for gender differences and parent-of-origin effects. Am J Gastroenterol. 2008;103:997–1003.
  • Husby S, Koletzko S, Korponay-Szabo IR, et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–160.